These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4118611)

  • 1. Mechanism of resistance to 5-azacytidine in Bacillus subtilis. I. Isolation and some properties of mutants resistant to 5-azacytidine and 5-aza-2'-deoxycytidine.
    Fucík V; Zadrazil S; Jurovcík M; Sormová Z
    Folia Microbiol (Praha); 1972; 17(6):517-21. PubMed ID: 4118611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between the instability in saline and the competence for genetic transformation in Bacillus subtilis].
    Grunow R
    Z Allg Mikrobiol; 1973; 13(8):639-45. PubMed ID: 4205483
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the mechanism of action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4(5)-carboxamide in Bacillus subtilis.
    Saunders PP; Schultz GA
    Biochem Pharmacol; 1970 Mar; 19(3):911-9. PubMed ID: 4994358
    [No Abstract]   [Full Text] [Related]  

  • 4. Transformation in bacillus subtilis: fate of transforming DNA in transformation deficient mutants.
    Buitenwerf J; Venema G
    Mol Gen Genet; 1977 Mar; 151(2):203-13. PubMed ID: 406513
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 5-azacytidine on DNA methylation and on the enzymes of de novo pyrimidine biosynthesis in Bacillus subtilis Marburg strain.
    Guha S
    Eur J Biochem; 1984 Nov; 145(1):99-106. PubMed ID: 6208029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Bromouracil-tolerant mutants of Bacillus subtilis.
    Bishop RJ; Sueoka N
    J Bacteriol; 1972 Nov; 112(2):870-6. PubMed ID: 4628747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and some characteristics of haemin dependent mutants of Bacillus subtilis.
    Anderson TJ; Ivánovics G
    J Gen Microbiol; 1967 Oct; 49(1):31-40. PubMed ID: 4965055
    [No Abstract]   [Full Text] [Related]  

  • 8. The properties of virginiamycin-resistant mutants of Bacillus subtilis.
    Cocito C; Fraselle G
    J Gen Microbiol; 1973 May; 76(1):115-25. PubMed ID: 4198713
    [No Abstract]   [Full Text] [Related]  

  • 9. A cluster of mutations determining erythromycin resistance in Bacillus subtilis.
    Chu CY; Iyer VN
    Can J Microbiol; 1973 Jun; 19(6):679-88. PubMed ID: 4197243
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of D-cycloserine resistant mutants in Bacillus subtilis.
    Gallori E; Fani R
    Microbiologica; 1983 Jan; 6(1):19-26. PubMed ID: 6405128
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigation of Bacillus subtilis mutants with changed capacity for formation of competent cells.
    Prozorov AA; Kalinina NA; Shilina VN
    Sov Genet; 1974 Mar; 7(12):1573-81. PubMed ID: 4208051
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isolation and 1st characterization of a temperature sensitive filamentous mutant of Bacillus subtilis SB 19].
    Mach F; Engelbrecht H
    Z Allg Mikrobiol; 1970; 10(6):383-95. PubMed ID: 4098705
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic analysis of ribonucleic acid polymerase mutants of Bacillus subtilis.
    Haworth SR; Brown LR
    J Bacteriol; 1973 Apr; 114(1):103-13. PubMed ID: 4144588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate-Mg2+ transport in Bacillus subtilis. Studies with 2-fluoro-L-erythro-citrate as a substrate.
    Oehr P; Willecke K
    J Biol Chem; 1974 Apr; 249(7):2037-42. PubMed ID: 4206548
    [No Abstract]   [Full Text] [Related]  

  • 15. A 3-deazauracil-resistant mutant of Bacillus subtilis with increased production of cytidine.
    Asahi S; Tsunemi Y; Izawa M; Doi M
    Biosci Biotechnol Biochem; 1995 May; 59(5):915-6. PubMed ID: 7787306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic reversion in some early blocked sporulation mutants of Bacillus subtilis: isolation and phenotype identification of partial revertants.
    Guespin-Michel JE
    J Bacteriol; 1971 Oct; 108(1):241-7. PubMed ID: 4331293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the development of competence by culture fluids in Bacillus subtilis transformation.
    Joenje H; Gruber M; Venema G
    Biochim Biophys Acta; 1972 Mar; 262(2):189-99. PubMed ID: 4622862
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816).
    Lloyd HH; Dulmadge EA; Wilkoff LJ
    Cancer Chemother Rep; 1972 Oct; 56(5):585-91. PubMed ID: 4119906
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic and chemical studies of ribosomes from spectinomycin resistant mutants of Bacillus subtilis.
    Kimura A; Kobata K; Takata R; Osawa S
    Mol Gen Genet; 1973 Aug; 124(2):107-15. PubMed ID: 4270516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Properties of mutants of Bacillus subtilis which are resistant to the isoleucine antagonist ketomycin].
    Krüpe H; Poralla K
    Arch Mikrobiol; 1972; 85(3):253-8. PubMed ID: 4629239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.